Identification of SLC15A3 as a shared prognostic biomarker for AML and COVID-19 via integrative bioinformatics, machine learning and Mendelian randomization
Acute myeloid leukemia (AML) is a lethal hematological malignancy with poor overall prognosis.COVID-19 co-infection further complicates clinical management and worsens survival outcomes of AML patients, highlighting the need to explore the molecular interplay between the two diseases. In this study, we initially scre...